Eli Lilly Gets European Approval to Sell Trulicity, a Type 2 Diabetes Drug
Tuesday, November 25, 2014 - 21:30
in Mathematics & Economics
The move by the European Commission puts pressure on the company’s Danish rival, Novo Nordisk, the market leader in its category.